HIV clinical trials

Keyphrases

Publications

volume 19, number 2, 2019

Ling Luo, Yang Han, Xiaojing Song, Ting Zhu, Yong Zeng, Taisheng Li
CD16-expressing monocytes correlate with arterial stiffness in HIV-infected ART-naïve men. HIV clinical trials 19 (2) (2019)
Maaike Krikke, Kiki Tesselaar, Guido E L van den Berk, Sigrid A Otto, Laura H Freriks, Steven F L van Lelyveld, Frank J L Visseren, Andy I M Hoepelman, Joop E Arends
The effect of switching protease inhibitors to raltegravir on endothelial function, in HIV-infected patients. HIV clinical trials 19 (2) (2019)

volume 19, number 3, 2019

Leonardo Calza, Vincenzo Colangeli, Marco Borderi, Roberto Manfredi, Lorenzo Marconi, Isabella Bon, Maria Carla Re, Pierluigi Viale
Rosuvastatin and atorvastatin preserve renal function in HIV-1-infected patients with chronic kidney disease and hyperlipidaemia. HIV clinical trials 19 (3) (2019)

volume 19, number 5, 2019

Álvaro Mena, Purificación Cid, Carlos Dueñas, María Ángeles Garcinuño, Juan Francisco Lorenzo, Luis Margusino, Marina Quiñones, Carmen Grande, Iria Rodríguez-Osorio, Ángeles Castro
Darunavir/cobicistat maintains the effectiveness of darunavir/ritonavir in HIV-infected patients under mono or dual therapy. HIV clinical trials 19 (5) (2019)

volume 19, number 6, 2019

Jenny Bischoff, Stefan Mauss, Christiane Cordes, Thomas Lutz, Stefan Scholten, Markus Cornberg, Michael P Manns, Axel Baumgarten, Jürgen K Rockstroh
Impact of CD4+ blood cell count and HIV viral load on treatment response with direct acting antivirals in HIV and HCV coinfected patients: insights from the German Hepatitis C-Registry. HIV clinical trials 19 (6) (2019)
Risa M Hoffman, Konstantia Nadia Angelidou, Sean S Brummel, Friday Saidi, Avy Violari, Dingase Dula, Vidya Mave, Lee Fairlie, Gerhard Theron, Moreen Kamateeka, Tsungai Chipato, Benjamin H Chi, Lynda Stranix-Chibanda, Teacler Nematadzira, Dhayendre Moodley, Debika Bhattacharya, Amita Gupta, Anne Coletti, James A McIntyre, Karin L Klingman, Nahida Chakhtoura, David E Shapiro, Mary Glenn Fowler, Judith S Currier, null null
Maternal health outcomes among HIV-infected breastfeeding women with high CD4 counts: results of a treatment strategy trial. HIV clinical trials 19 (6) (2019)
Jack E Burkhalter, David M Aboulafia, Maria Botello-Harbaum, Jeannette Y Lee
Participant characteristics and clinical trial decision-making factors in AIDS malignancy consortium treatment trials for HIV-infected persons with cancer (AMC #S006). HIV clinical trials 19 (6) (2019)
Amedeo Ferdinando Capetti, Giuseppe Vittorio De Socio, Maria V Cossu, Gaetana Sterrantino, Giovanni Cenderello, Annamaria Cattelan, Gianmaria Baldin, Alessandro Soria, Niccolò Riccardi, Fosca P Niero, Benedetto M Celesia, Giorgio Barbarini, Stefano Rusconi, Giuliano Rizzardini
Durability of dolutegravir plus boosted darunavir as salvage or simplification of salvage regimens in HIV-1 infected, highly treatment-experienced subjects. HIV clinical trials 19 (6) (2019)

volume 19, number 1, 2018

Juan A Pineda, Antonio Rivero-Juárez, Ignacio de Los Santos, Antonio Ramón Collado-Romacho, Dolores Merino, Luis Enrique Morano, María J Ríos, Montserrat Pérez-Pérez, Francisco Téllez, Rosario Palacios, Ana B Pérez, María Mancebo, Antonio Rivero, Juan Macías
Paritaprevir/ritonavir/ombitasvir plus dasabuvir in HIV/HCV-coinfected patients with genotype 1 in real-life practice. HIV clinical trials 19 (1) (2018)
Sharon M Coleman, Natalia Gnatienko, Christine A Lloyd-Travaglini, Michael R Winter, Carly Bridden, Elena Blokhina, Dmitriy A Lioznov, Julian Adong, Jeffrey H Samet, Teri Liegler, Judith A Hahn
False-positive HIV diagnoses: lessons from Ugandan and Russian research cohorts. HIV clinical trials 19 (1) (2018)

volume 18, number 3, 2018

Karin Neukam, Luis E Morano-Amado, Antonio Rivero-Juárez, María Mancebo, Rafael Granados, Francisco Téllez, Antonio Collado, María J Ríos, Ignacio de Los Santos-Gil, Sergio Reus-Bañuls, Francisco Vera-Méndez, Paloma Geijo-Martínez, Marta Montero-Alonso, Marta Suárez-Santamaría, Juan A Pineda
HIV-coinfected patients respond worse to direct-acting antiviral-based therapy against chronic hepatitis C in real life than HCV-monoinfected individuals: a prospective cohort study. HIV clinical trials 18 (3) (2018)

volume 18, number 4, 2018

Rima Kulkarni, Sally L Hodder, Huyen Cao, Silvia Chang, Michael D Miller, Kirsten L White
Week 48 resistance analysis of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF versus Atazanavir + Ritonavir + Emtricitabine/Tenofovir DF in HIV-1 infected women (WAVES study GS-US-236-0128). HIV clinical trials 18 (4) (2018)

volume 18, number 5-6, 2018

Chan-Loi Yong, Joseph C Gathe, Gabriele Knecht, Catherine Orrell, Josep Mallolas, Daniel Podzamczer, Benoit Trottier, Wei Zhang, John P Sabo, Richard Vinisko, Murray Drulak, Anne-Marie Quinson
Pharmacokinetic analysis of nevirapine extended release 400 mg once daily vs nevirapine immediate release 200 mg twice daily formulation in treatment-naïve patients with HIV-1 infection. HIV clinical trials 18 (5-6) (2018)
Ashley E Davis, Anita J Brogan, Bridgett Goodwin, Gonzalo Nocea, Virginia Lozano
Short-term cost and efficiency analysis of raltegravir versus atazanavir/ritonavir or darunavir/ritonavir for treatment-naive adults with HIV-1 infection in Spain. HIV clinical trials 18 (5-6) (2018)
David M Asmuth, John E Hinkle, Anthony LaMarca, Carl J Fichtenbaum, Ma Somsouk, Netanya S Utay, Audrey L Shaw, Bryon W Petschow, Christopher J Detzel, Eric M Weaver
Evaluation of oral serum-derived bovine immunoglobulins in HIV-infected patients with chronic idiopathic diarrhea. HIV clinical trials 18 (5-6) (2018)

volume 16, number 2, 2018

Juergen K Rockstroh, Vicente Soriano, Frank Plonski, Meena Bansal, Gerd Fätkenheuer, Catherine B Small, David M Asmuth, Gilles Pialoux, Geoffrey Mukwaya, Shyla Jagannatha, Jayvant Heera, Juan A Pineda
Hepatic safety in subjects with HIV-1 and hepatitis C and/or B virus: a randomized, double-blind study of maraviroc versus placebo in combination with antiretroviral agents. HIV clinical trials 16 (2) (2018)

volume 16, number 3, 2018

Benoit Trottier, Chrissi Galanakis, Danièle Longpré, Harold Dion, Sylvie Vézina, Stéphane Lavoie, Michel Boissonnault, Cecilia Costiniuk, Mohammad-Ali Jenabian, Nimâ Machouf, Réjean Thomas
Removing inactive NRTIs in a salvage regimen is safe, maintains virological suppression and reduces treatment costs: results from the VERITAS study (TMC114HIV4054). HIV clinical trials 16 (3) (2018)

volume 19, number 1, 2017

E Molas, S Luque, A Retamero, D Echeverría-Esnal, A Guelar, M Montero, Roberto Güerri-Fernandez, L Sorli, E Lerma, Judit Villar-García, H Knobel
Frequency and severity of potential drug interactions in a cohort of HIV-infected patients Identified through a Multidisciplinary team. HIV clinical trials 19 (1) (2017)
Akil Jackson, Laura Else, Christopher Higgs, Zeenat Karolia, Saye Khoo, David Back, Emma Devitt, Anton Pozniak, Marta Boffito
Pharmacokinetics and pharmacodynamics of the nucleoside sparing dual regimen containing rilpivirine plus darunavir/ritonavir in treatment-naïve HIV-1-infected individuals. HIV clinical trials 19 (1) (2017)
Felix G Mhlanga, Lisa M Noguchi, Jennifer E Balkus, Samuel Kabwigu, Rachel Scheckter, Jeanna Piper, Heather Watts, Colin O'Rourke, Kristine Torjesen, Elizabeth R Brown, Sharon L Hillier, Richard Beigi
Implementation of a prospective pregnancy registry for antiretroviral based HIV prevention trials. HIV clinical trials 19 (1) (2017)

volume 18, number 2, 2017

Maile Y Karris, Sonia Jain, Tyler R C Day, Josué Pérez-Santiago, Miguel Goicoechea, Michael P Dubé, Xiaoying Sun, Celsa Spina, Eric S Daar, Richard H Haubrich, Sheldon Morris, null null
HIV viral kinetics and T cell dynamics in antiretroviral naïve persons starting an integrase strand transfer inhibitor and protease inhibitor regimen. HIV clinical trials 18 (2) (2017)

volume 18, number 3, 2017

Susan H Eshleman, Ethan A Wilson, Xinyi C Zhang, San-San Ou, Estelle Piwowar-Manning, Joseph J Eron, Marybeth McCauley, Theresa Gamble, Joel E Gallant, Mina C Hosseinipour, Nagalingeswaran Kumarasamy, James G Hakim, Ben Kalonga, José Henrique Pilotto, Beatriz Gilda Jegerhorn Grinsztejn, Sheela V Godbole, Nuntisa Chotirosniramit, Breno Riegel Santos, Emily Shava, Lisa A Mills, Ravindre Panchia, Noluthando Mwelase, Kenneth H Mayer, Ying Q Chen, Myron S Cohen, Jessica M Fogel
Virologic outcomes in early antiretroviral treatment: HPTN 052. HIV clinical trials 18 (3) (2017)
P McGettrick, B Ghavami-Kia, W Tinago, Alan J Macken, J O'Halloran, J S Lambert, G Sheehan, P W G Mallon
The HIV Care Cascade and sub-analysis of those linked to but not retained in care: the experience from a tertiary HIV referral service in Dublin Ireland. HIV clinical trials 18 (3) (2017)
Frank A Post, Yazdan Yazdanpanah, Gabriel Schembri, Adriano Lazzarin, Jacques Reynes, Franco Maggiolo, Mingjin Yan, Michael E Abram, Cecilia Tran-Muchowski, Andrew Cheng, Martin S Rhee
Efficacy and safety of emtricitabine/tenofovir alafenamide (FTC/TAF) vs. emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) as a backbone for treatment of HIV-1 infection in virologically suppressed adults: subgroup analysis by third agent of a randomized, double-blind, active-controlled phase 3 trial<sup/>. HIV clinical trials 18 (3) (2017)
Jose R Arribas, Edwin DeJesus, Jan van Lunzen, Christine Zurawski, Manuela Doroana, William Towner, Adriano Lazzarin, Mark Nelson, Damian McColl, Kristen Andreatta, Raji Swamy, Javier Szwarcberg, Thai Nguyen
Simplification to single-tablet regimen of elvitegravir, cobicistat, emtricitabine, tenofovir DF from multi-tablet ritonavir-boosted protease inhibitor plus coformulated emtricitabine and tenofovir DF regimens: week 96 results of STRATEGY-PI. HIV clinical trials 18 (3) (2017)
Leonardo Calza, Vincenzo Colangeli, Eleonora Magistrelli, Nicolo' Rossi, Elena Rosselli Del Turco, Linda Bussini, Marco Borderi, Pierluigi Viale
Prevalence of metabolic syndrome in HIV-infected patients naive to antiretroviral therapy or receiving a first-line treatment. HIV clinical trials 18 (3) (2017)

volume 18, number 4, 2017

Sahera Dirajlal-Fargo, Abdus Sattar, Manjusha Kulkarni, Nicholas Funderburg, Grace A McComsey
Soluble TWEAK may predict carotid atherosclerosis in treated HIV infection. HIV clinical trials 18 (4) (2017)
Christel Protière, Marie Préau, Marjolaine Doumergue, Marion Mora, Olivier Lambotte, Bruno Spire, Marie Suzan-Monti
Will CURE trials introduce an uncomfortable revolution in the field of HIV research? HIV clinical trials 18 (4) (2017)
Mark J Siedner, Mwebesa B Bwana, Mahomed-Yunus S Moosa, Michelle Paul, Selvan Pillay, Suzanne McCluskey, Isaac Aturinda, Kevin Ard, Winnie Muyindike, Pravikrishnen Moodley, Jaysingh Brijkumar, Tamlyn Rautenberg, Gavin George, Brent Johnson, Rajesh T Gandhi, Henry Sunpath, Vincent C Marconi
The REVAMP trial to evaluate HIV resistance testing in sub-Saharan Africa: a case study in clinical trial design in resource limited settings to optimize effectiveness and cost effectiveness estimates. HIV clinical trials 18 (4) (2017)
Anton Pozniak, Jason Flamm, Andrea Antinori, Mark Bloch, Douglas Ward, Juan Berenguer, Pierre Côté, Kristen Andreatta, William Garner, Javier Szwarcberg, Thai Nguyen-Cleary, Damian J McColl, David Piontkowsky
Switching to the single-tablet regimen of elvitegravir, cobicistat, emtricitabine, and tenofovir DF from non-nucleoside reverse transcriptase inhibitor plus coformulated emtricitabine and tenofovir DF regimens: Week 96 results of STRATEGY-NNRTI. HIV clinical trials 18 (4) (2017)

volume 18, number 5-6, 2017

Erkki Lathouwers, Eric Y Wong, Donghan Luo, Sareh Seyedkazemi, Sandra De Meyer, Kimberley Brown
HIV-1 resistance rarely observed in patients using darunavir once-daily regimens across clinical studies. HIV clinical trials 18 (5-6) (2017)
Amy Cutrell, Deborah J Donnell, David T Dunn, David V Glidden, Anneke Grobler, Brett Hanscom, Britt S Stancil, R Daniel Meyer, Ronnie Wang, Robert L Cuffe
HIV prevention trial design in an era of effective pre-exposure prophylaxis. HIV clinical trials 18 (5-6) (2017)

HIV clinical trials

Keyphrases

Publications

volume 19, number 2, 2019

volume 19, number 3, 2019

volume 19, number 5, 2019

volume 19, number 6, 2019

volume 19, number 1, 2018

volume 19, number 2, 2018

volume 19, number 3, 2018

volume 19, number 4, 2018

volume 19, number 5, 2018

volume 18, number 3, 2018

volume 18, number 4, 2018

volume 18, number 5-6, 2018

volume 16, number 2, 2018

volume 16, number 3, 2018

volume 19, number 1, 2017

volume 18, number 2, 2017

volume 18, number 3, 2017

volume 18, number 4, 2017

volume 18, number 5-6, 2017